SEI Investments’s Neuropace NPCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.6M Buy
121,476
+41,233
+51% +$619K ﹤0.01% 2120
2025
Q4
$1.24M Buy
+80,243
New +$1.07M ﹤0.01% 2081

Other funds holding NPCE

SEI Investments's NPCE Position: Q1 2026 in Review

SEI Investments increased its Neuropace (NPCE) stake by 51% in Q1 2026, buying an estimated $619K and bringing the position to 121,476 shares worth $1.6M. The position accounts for ﹤0.01% of the portfolio, ranked #2120.

SEI Investments first reported a position in NPCE in Q4 2025 and has held it in 2 quarters since. 113 funds tracked by Wall St. Rank hold NPCE as of Q1 2026.

  • SEI Investments held 121,476 shares of Neuropace worth $1.6M as of Q1 2026.
  • SEI Investments bought 41,233 Neuropace shares in Q1 2026, an estimated $619K.
  • Neuropace made up ﹤0.01% of SEI Investments's portfolio in Q1 2026, its #2120 holding.
  • SEI Investments first reported a position in Neuropace in Q4 2025 and has held it in 2 quarters since.
  • 113 funds tracked by Wall St. Rank held Neuropace as of Q1 2026.

Based on SEI Investments's 13F filing for Q1 2026, filed 13 May 2026.